S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
NYSE:ALR

Alere (ALR) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$1.32
$1.32
50-Day Range
N/A
52-Week Range
$34.41
$51.00
Volume
N/A
Average Volume
40,839 shs
Market Capitalization
$43.05 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ALR stock logo

About Alere Stock (NYSE:ALR)

Alere Inc. is a provider of health information through diagnostic tests. The Company's segments include professional diagnostics, consumer diagnostics, and corporate and other. The professional diagnostics segment includes an array of diagnostic test products and other in vitro diagnostic tests marketed to medical professionals and laboratories for detection of diseases and conditions within its areas of focus. The consumer diagnostics segment consists primarily of manufacturing operations related to its role as the exclusive manufacturer of products for SPD Swiss Precision Diagnostics (SPD), its joint venture with The Procter & Gamble Company (P&G). The Company's professional diagnostic solutions allow patients and their healthcare providers to work together to manage patients' conditions over the continuum of care, from the hospital to home. The Company offers lines of drugs-of-abuse tests, reagent systems and laboratory testing options.

ALR Stock News Headlines

Alro SA ALR
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
ABP Acquisition to Acquire AlerisLife for $1.31 Per Share
AlerisLife Inc. Announces Third Quarter 2022 Results
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
AlerisLife Inc. (ALR)
ALR_pb Historical Data
AlerisLife Inc. Announces Second Quarter 2022 Results
AlerisLife Provides a Business Update
See More Headlines
Receive ALR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alere and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/04/2016
Today
4/18/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Skilled nursing care facilities
Sub-Industry
Health Care Supplies
CUSIP
01449J10
Employees
10,400
Year Founded
N/A

Profitability

Net Income
$-29,920,000.00
Pretax Margin
-5.29%

Debt

Sales & Book Value

Annual Sales
$934.59 million
Book Value
$5.72 per share

Miscellaneous

Free Float
29,870,000
Market Cap
$43.05 million
Optionable
Optionable
Beta
0.85
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Gregg J. Powers
    Independent Chairman of the Board
  • Namal Nawana
    President, Chief Executive Officer, Director
  • James F. Hinrichs
    Chief Financial Officer, Executive Vice President
  • Daniella Cramp
    Global President - Cardiometabolic Business Unit
  • Sanjay Malkani
    Global President - Toxicology
  • Avi Pelossof
    Global President - Infectious Disease Business Unit
  • Ellen Chiniara J.D.
    Senior Vice President, General Counsel, Chief Ethics and Compliance Officer, Secretary
  • Robert Hargadon
    Senior Vice President - Global Human Resources
  • John Bridgen Ph.D.
    Senior Vice President - Business Development
  • Mark Gladwell
    Senior Vice President - Global Operations

ALR Stock Analysis - Frequently Asked Questions

How were Alere's earnings last quarter?

Alere Inc. (NYSE:ALR) announced its earnings results on Friday, November, 4th. The medical research company reported $0.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.54 by $0.35. The medical research company had revenue of $582 million for the quarter, compared to analysts' expectations of $605.50 million. Alere had a negative net margin of 5.34% and a negative trailing twelve-month return on equity of 20.78%. The company's revenue for the quarter was down 3.6% compared to the same quarter last year. During the same period in the prior year, the business earned ($0.10) earnings per share.

What other stocks do shareholders of Alere own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Alere investors own include Morgan Stanley (MS), BioTelemetry (BEAT), Abbott Laboratories (ABT), FireEye (FEYE), Twitter (TWTR), Allergan (AGN), AEGR (AEGR), Ashmore Group (ASHM), Chembio Diagnostics (CEMI) and Capitala Finance (CPTA).

This page (NYSE:ALR) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners